参考文献/References:
[1] 章晋伟, 曹刚琴, 汪建. 视网膜母细胞瘤组织中赖氨酸羟化酶2 表达及其对瘤细胞迁移和侵袭的影响[J].现代检验医学杂志, 2022, 37(3): 105-109, 161. ZHANG Jinwei, CAO Gangqin, WANG Jian. Expression of procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 in retinoblastoma and its effect on tumor cell migration and invasion[J]. Journal of Modern Laboratory Medicine, 2022, 37(3): 105-109,161.
[2] 林壮玲. 视网膜母细胞瘤诊疗的研究进展[J]. 眼科学报, 2020, 35(4): 271-278. LIN Zhuangling. Research progress on the diagnosis and treatment of retinoblastoma[J]. Eye Science, 2020,35(4): 271-278.
[3] CHOI S W, KIM H W, NAM J W. The small peptide world in long noncoding RNAs[J]. Briefings in Bioinformatics, 2019, 20(5): 1853-1864.
[4] NAIR L, CHUNG H, BASU U. Regulation of long non-coding RNAs and genome dynamics by the RNA surveillance machinery[J]. Nature Reviews Molecular Cell Biology, 2020, 21(3): 123-136.
[5] 关李稳, 刘真义, 周真真, 等. 溃疡性结肠炎患者血清LncRNA TUG1 和miR-142-5p 表达与疾病活动度及预后的关系[J]. 现代检验医学杂志, 2023, 38(5):70-74, 79. GUAN Liwen, LIU Zhenyi, ZHOU Zhenzhen, et al. Relationship between serum LncRNA TUG1 and miR-142-5p expression and disease activity and prognosis in patients with ulcerative colitis[J]. Journal of Modern Laboratory Medicine, 2023, 38(5): 70-74, 79.
[6] 何静. 外周血LncRNA NEAT1 在恶性肿瘤诊断中的研究进展[J]. 现代医药卫生, 2023, 39(10): 1732-1736. HE Jing. Research progress of peripheral blood LncRNA NEAT1 in diagnosis of malignant tumors[J].Journal of Modern Medicine & Health, 2023, 39(10):1732-1736.
[7] 陈日红, 杨依玲, 范大伟, 等. 微RNA-132 和FOXA1在视网膜母细胞瘤中的表达水平及意义[J]. 重庆医学, 2020, 49(22): 3778-3782. CHEN Rihong, YANG Yiling, FAN Dawei, et al. The expression levels of microRNA-132 and FOXA1 in retinoblastoma and their significance[J]. Chongqing Medicine, 2020, 49(22): 3778-3782.
[8] 郝冰, 李佳, 李秀红, 等. 118 例视网膜母细胞瘤临床治疗分析[J]. 第三军医大学学报, 2020, 42(9):942-947. HAO Bing, LI Jia, LI Xiuhong, et al. Clinical treatment for retinoblastoma: report of 118 cases[J]. Journal of Third Military Medical University, 2020, 42(9): 942-947.
[9] TAN Yuetao, LIN Jinfei, LI Ting, et al. LncRNAmediated posttranslational modifications and reprogramming of energy metabolism in cancer[J].Cancer Communications (London, England), 2021,41(2): 109-120.
[10] GAO Yunxia, GAO Haoxiang, XU Xiaoyun, et al. Effects of LncRNA MALAT1 and LncRNA NKILA on proliferation, invasion and apoptosis of retinoblastoma[J]. European Review for Medical and Pharmacological Sciences, 2020, 24(16): 8296-8307.
[11] 付晓, 黄蕊, 范先群, 等. 长链非编码RNA 在眼内恶性肿瘤中的作用及其机制[J]. 上海交通大学学报(医学版), 2018, 38(6): 699-703. FU Xiao, HUANG Rui, FAN Xianqun, et al. Roles of long non-coding RNA in intraocular malignant tumor and its mechanisms[J]. Journal of Shanghai Jiaotong University (Medical Science), 2018, 38(6): 699-703.
[12] 李芳芳, 葛星星, 朱坚胜. LncRNA Neat1 在肝细胞癌组织和细胞株中的表达及临床意义[J]. 浙江医学,2020, 42(19): 2067-2070, 2074. LI Fangfang, GE Xingxing, ZHU Jiansheng. Expression and clinical significance of LncRNA NEAT1 in hepatocellular carcinoma tissues and cell lines[J].Zhejiang Medical Journal, 2020, 42(19): 2067-2070,2074.
[13] PANG Yamei, WU Jie, LI Xiang, et al. NEAT1/miR-124/STAT3 feedback loop promotes breast cancer progression[J]. International Journal of Oncology,2019, 55(3): 745-754.
[14] YU P F, WANG Y, L? W, et al. LncRNA NEAT1/miR-1224/KLF3 contributes to cell proliferation, apoptosis and invasion in lung cancer[J]. European Review for Medical and Pharmacological Sciences, 2019, 23(19):8403-8410.
[15] XIA Ying, ZHOU Yu, HAN Han, et al. LncRNA NEAT1 facilitates melanoma cell proliferation,migration, and invasion via regulating miR-495-3p and E2F3[J]. Journal of Cellular Physiology, 2019, 234(11):19592-19601.
[16] LIANG Jingshan, LIU Changtao, XU Dezhi, et al. LncRNA NEAT1 facilitates glioma progression via stabilizing PGK1[J]. Journal of Translational Medicine,2022, 20(1): 80.
[17] KOU J T, MA J, ZHU J Q, et al. LncRNA NEAT1 regulates proliferation, apoptosis and invasion of liver cancer [J]. European Review for Medical and Pharmacological Sciences, 2020, 24(8): 4152-4160.
[18] LI Ou, JIANG Bo, YI Weimin, et al. LncRNA NEAT1 promotes cell proliferation, migration,and invasion via the miR-186-5p/PTP4A1 axis in cholangiocarcinoma[J]. Kaohsiung Journal of Medical Sciences, 2021, 37(5): 379-391.
相似文献/References:
[1]章晋伟,曹刚琴,汪 建.视网膜母细胞瘤组织中赖氨酸羟化酶2表达及其对瘤细胞迁移和侵袭的影响[J].现代检验医学杂志,2022,37(03):105.[doi:10.3969/j.issn.1671-7414.2022.03.022]
ZHANG Jin-wei,CAO Gang-qin,WANG Jian.Expression of Procollagen-lysine 2-Oxoglutarate 5-Dioxygenase 2 in Retinoblastoma and Its Effect on Tumor Cell Migration and Invasion[J].Journal of Modern Laboratory Medicine,2022,37(03):105.[doi:10.3969/j.issn.1671-7414.2022.03.022]
[2]罗 钢,蔡丽英,呙 明.视网膜母细胞瘤组织中miR-142的表达及对细胞增殖和侵袭力的影响[J].现代检验医学杂志,2022,37(03):144.[doi:10.3969/j.issn.1671-7414.2022.03.030]
LUO Gang,CAI Li-ying,GUO Ming.Expression of miR-142 in Retinoblastoma Tissues and Influences on Cell Proliferation and Invasiveness[J].Journal of Modern Laboratory Medicine,2022,37(03):144.[doi:10.3969/j.issn.1671-7414.2022.03.030]
[3]聂晓慧,薛 茜,寇文辉,等.急性脑梗死患者外周血LncRNA-NEAT1,miR-93-5p 表达水平及临床意义[J].现代检验医学杂志,2022,37(06):94.[doi:10.3969/j.issn.1671-7414.2022.06.017]
NIE Xiao-hui,XUE Qian,KOU Wen-hui,et al.Expression Level and Clinical Significance of Peripheral Blood LncRNANEAT1 and miR-93-5p in Patients with Acute Cerebral Infarction[J].Journal of Modern Laboratory Medicine,2022,37(03):94.[doi:10.3969/j.issn.1671-7414.2022.06.017]
[4]刘 慧,钟娇影,刘 杰,等.糖尿病肾病患者血清miR-495-3p 和LncRNA NEAT1 表达水平及其与患者预后的相关性研究[J].现代检验医学杂志,2023,38(03):35.[doi:10.3969/j.issn.1671-7414.2023.03.007]
LIU Hui,ZHONG Jiao-ying,LIU Jie,et al.Study on the Expression Levels of Serum miR-495-3p and LncRNA NEAT1 in Diabetic Nephropathy and Their Relationship with Prognosis of Patients[J].Journal of Modern Laboratory Medicine,2023,38(03):35.[doi:10.3969/j.issn.1671-7414.2023.03.007]